Page last updated: 2024-12-10

bacillomycin d

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bacillomycin D: from strain of Bacillus subtilis; contains lipid moiety which is mixture of 3-amino-12-methyltridecanoic acid (40%) & 3-amino-12-methyltetradecanoic acid (60%) & peptide moiety: L-Asp(1), L-Glu(1), L-Pro(1), D-Ser(1), L-Thr(1) & D-Tyr(1); two moieties joined by threonyl beta-aminoacid linkage; see also bacillomycin L & bacillomycin S [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3086051
MeSH IDM0090171

Synonyms (4)

Synonym
bacillomycin
bacillomycin d
76012-17-4
Q4838953

Research Excerpts

Overview

Bacillomycin D is a natural antimicrobial lipopeptide belonging to the iturin family. It is an antifungal agent extracted from the culture medium of a strain of Bacillus subtilis.

ExcerptReferenceRelevance
"Bacillomycin D is a cyclic antimicrobial lipopeptide that has excellent antifungal effects, but its application is limited due to its low yield. "( Effect and regulation of fatty acids on bacillomycin D synthesis.
Bie, X; Lu, Z; Lv, Z; Ma, W; Meng, F; Wang, Z; Zhang, P; Zheng, L; Zhou, L, 2023
)
2.62
"Bacillomycin D is a natural antimicrobial lipopeptide belonging to the iturin family. "( Conformational analyses of bacillomycin D, a natural antimicrobial lipopeptide, alone or in interaction with lipid monolayers at the air-water interface.
Besson, F; Nasir, MN, 2012
)
2.12
"Bacillomycin D is an antifungal agent extracted from the culture medium of a strain of Bacillus subtilis. "( Structure of bacillomycin D, a new antibiotic of the iturin group.
Besson, F; Delcambe, L; Michel, G; Peypoux, F, 1981
)
2.07
"Bacillomycin D is an antifungal lipopeptide produced by B. "( Biosynthesis of bacillomycin D by Bacillus subtilis. Evidence for amino acid-activating enzymes by the use of affinity chromatography.
Besson, F; Michel, G, 1992
)
2.07

Actions

Bacillomycin D promotes the transcription of the iron ABC transporter FeuABC. It can inhibit the growth of Aspergillus ochraceus in food samples.

ExcerptReferenceRelevance
"Bacillomycin D promotes the transcription of the iron ABC transporter FeuABC by binding to its transcription factor, Btr."( Antibiotic Bacillomycin D Affects Iron Acquisition and Biofilm Formation in Bacillus velezensis through a Btr-Mediated FeuABC-Dependent Pathway.
Feng, H; Liu, Y; Mandic-Mulec, I; Shen, Q; Sun, X; Xu, Z; Xun, W; Zhang, H; Zhang, N; Zhang, R, 2019
)
1.63
"Bacillomycin D can inhibit the growth of Aspergillus ochraceus in food samples. "( Bacillomycin D-C16 triggers apoptosis of gastric cancer cells through the PI3K/Akt and FoxO3a signaling pathways.
Huang, Z; Li, W; Lin, F; Lu, Z; Lv, F; Muhammad, U; Sun, J; Yang, J, 2019
)
3.4

Compound-Compound Interactions

Bacillomycin D and its combination with amphotericin B display impressive anti-biofilm and wound-healing activities. The study was carried out by crystal violet colorimetric method.

ExcerptReferenceRelevance
"The antibiofilm activity of bacillomycin D and its combination with amphotericin B was carried out by crystal violet colorimetric method."( Bacillomycin D and its combination with amphotericin B: promising antifungal compounds with powerful antibiofilm activity and wound-healing potency.
Alfeddy, MN; Azaiez, S; Ben Slimene, I; Casciaro, B; Di Grazia, A; Elkahoui, S; Karkouch, I; Limam, F; Luca, V; Mangoni, ML; Tabbene, O, 2016
)
2.17
"Bacillomycin D and its combination with amphotericin B display impressive anti-biofilm and wound-healing activities."( Bacillomycin D and its combination with amphotericin B: promising antifungal compounds with powerful antibiofilm activity and wound-healing potency.
Alfeddy, MN; Azaiez, S; Ben Slimene, I; Casciaro, B; Di Grazia, A; Elkahoui, S; Karkouch, I; Limam, F; Luca, V; Mangoni, ML; Tabbene, O, 2016
)
3.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (10.00)18.7374
1990's3 (6.00)18.2507
2000's6 (12.00)29.6817
2010's29 (58.00)24.3611
2020's7 (14.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.62 (24.57)
Research Supply Index3.95 (2.92)
Research Growth Index5.23 (4.65)
Search Engine Demand Index41.24 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.96%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other50 (98.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]